Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug;29(4):479-86.
doi: 10.1007/s40620-016-0269-6. Epub 2016 Feb 3.

IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

Affiliations
Review

IgM nephropathy: is it closer to minimal change disease or to focal segmental glomerulosclerosis?

R Brugnano et al. J Nephrol. 2016 Aug.

Abstract

Immunoglobulin (Ig)M nephropathy (IgMN), known since 1978, is a very controversial clinicopathological entity characterized by IgM diffuse deposits in the mesangium at immunofluorescence whereas light microscop identifies minimal glomerular lesion, hypercellularity and expansion of the mesangium or sclerotic focal, segmental lesion. Clinically, it is a nephrotic syndrome, especially in pediatric patients, or asymptomatic proteinuria and/or isolated hematuria. These characteristics narrowly define IgMN between minimal change disease and focal segmental glomerulosclerosis, so it is not often recognized as a separate pathology. Homogeneous epidemiologic, pathogenetic, clinical or histological data are not available. Recent research on the pathogenetic role of mesangial IgM has, however, renewed interest in IgMN and naturally the controversies.

Keywords: Controversy; Focal segmental glomerulosclerosis; IgM nephropathy; Minimal change disease; Nephrotic syndrome.

PubMed Disclaimer

References

    1. Nephron. 1983;35(1):1-5 - PubMed
    1. PLoS One. 2015 Sep 03;10(9):e0136558 - PubMed
    1. Clin Sci (Lond). 2004 Aug;107(2):125-36 - PubMed
    1. Arch Pathol Lab Med. 1977 Jul;101(7):345-9 - PubMed
    1. Lab Invest. 1978 Jul;39(1):21-9 - PubMed

MeSH terms

Substances

LinkOut - more resources